icone plus
Contact Abonnez-vous aux actualités
Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
Moderate
The actual benefit of AETOXISCLEROL is moderate.
eNq1mF1v2jAUhu/5FVHuSQhtaTsFqo21G1KrMlq0aTeVSQ7FLLXTY5uP/fo5hGowOepw8GVs5z0nPq8fHyW+Wr1k3gJQUM66fhS0fA9YwlPKnrv++PGmeeFf9RrxnCzIzrLzoBVEbd9LMiJE1y9mgwkQJoIfd7efQb8P6PcaXswnc0jk3jolaRZ8JWJ2R/JijRcvOE29F5Aznnb9XMnNqBcLiTqL3pLjL5GTBOJwO7I7O3863R2Pw0LsP1SVALwl7NkoCsxKM1GIwGSfSHjmuK7I98RKm4oRCK4wgSGRsyHyBU0hNYaYkkyAVZDpMn0AXGQgiyBG8XCevAgrcTInqxG8DsxJf9SzfbmSzVYzOu+0Oq3L05PTs4u2VSjc2SpzFfRHhMlT1O60Ts4jy4IMOUqSOSoFFf19NzmKg/D6bslTKvKMrIO5yG23iiDR04D6zLv7kOILHlFTKNN79o8+U1kWHpj1eMsIRxkXCOpzxWQFKm5GthvR50zCqrqidnSTq60XKYjjyf7mzEz2oZpkNLHlmCaNAiHHo0E1xmoT4BMRMEZ3CPhOWcqX4vho2S2lo+zzDR2Nojmm0VP78qITnZ1Zn5yf2jcVd8m1Qp5DqKFDRR2WDNiU16WItqJZ6s2I9Ty4aWN4QjKoaGSalhTR5nvru5zZ293RKSeMol+uH2098U0Brh82j0ZpmnbrVTNxwW3twMrED/dzeaydtLgKzbiYSZmLD2G4XC6DGRFNQfQuBVM8DsN37kp3XbWTC7lsUEoOOkp9Ul5wh5XF9ni9d2XXbUO372/bXWMMiQpq1KIksTNeDq6Pj+C/PaiztId7yHAXZtMvEkk5c9XSqIlRsS6CBuwGNSDup1Na8Zej0pdxWP5h6TXisPi70mv8AfLk1AE=
hrnHrsQdQ5HJNEXV
Listen
